Atlas Trials

Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia

Clinical trial NCT03266913 · UNKNOWN

Trial details

NCT number
NCT03266913
Sponsor
Hormozgan University of Medical Sciences
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperbilirubinemia, Neonatal
Start date
2017-08-01
Primary completion
2017-10-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.